The Francis Crick Institute
jem_20230037.pdf (5.56 MB)

Type I interferons drive MAIT cell functions against bacterial pneumonia

Download (5.56 MB)
Version 2 2023-08-02, 17:09
Version 1 2023-07-28, 10:51
journal contribution
posted on 2023-08-02, 17:09 authored by Juan Carlos López-Rodríguez, Steven J Hancock, Kelin Li, Stefania Crotta, Christopher Barrington, Alejandro Suárez-Bonnet, Simon L Priestnall, Jeffrey Aubé, Andreas Wack, Paul Klenerman, Jose A Bengoechea, Patricia Barral
Mucosal-associated invariant T (MAIT) cells are abundant in the lung and contribute to host defense against infections. During bacterial infections, MAIT cell activation has been proposed to require T cell receptor (TCR)–mediated recognition of antigens derived from the riboflavin synthesis pathway presented by the antigen-presenting molecule MR1. MAIT cells can also be activated by cytokines in an MR1-independent manner, yet the contribution of MR1- dependent vs. -independent signals to MAIT cell functions in vivo remains unclear. Here, we use Klebsiella pneumoniae as a model of bacterial pneumonia and demonstrate that MAIT cell activation is independent of MR1 and primarily driven by type I interferons (IFNs). During Klebsiella infection, type I IFNs stimulate activation of murine and human MAIT cells, induce a Th1/cytotoxic transcriptional program, and modulate MAIT cell location within the lungs. Consequently, adoptive transfer or boosting of pulmonary MAIT cells protect mice from Klebsiella infection, with protection being dependent on direct type I IFN signaling on MAIT cells. These findings reveal type I IFNs as new molecular targets to manipulate MAIT cell functions during bacterial infections.


Crick (Grant ID: CC1107, Grant title: STP Bioinformatics & Biostatistics) Crick (Grant ID: CC2085, Grant title: Wack CC2085) Crick (Grant ID: CC1061, Grant title: STP Experimental Histopathology)